Legacy Capital Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$539K Buy
5,215
+70
+1% +$6.25K 0.1% 187
2026
Q1
$370K Buy
5,145
+603
+13% +$46.5K 0.08% 261
2025
Q4
$360K Sell
4,542
-135
-3% -$10.6K 0.08% 266
2025
Q3
$353K Sell
4,677
-33
-0.7% -$2.26K 0.08% 282
2025
Q2
$325K Buy
4,710
+537
+13% +$35.2K 0.07% 288
2025
Q1
$283K Buy
+4,173
New +$250K 0.07% 288
2024
Q1
Sell
-8,982
Closed -$709K 167
2023
Q4
$709K Sell
8,982
-1,055
-11% -$75.1K 0.2% 105
2023
Q3
$701K Buy
+10,037
New +$711K 0.19% 111
2023
Q2
Sell
-8,959
Closed -$666K 86
2023
Q1
$666K Buy
+8,959
New +$751K 0.18% 110

Other funds holding CVS

Legacy Capital Wealth Partners's CVS Position: Q2 2026 in Review

Legacy Capital Wealth Partners increased its CVS Health (CVS) stake by 1.4% in Q2 2026, buying an estimated $6.25K and bringing the position to 5,215 shares worth $539K. The position accounts for 0.1% of the portfolio, ranked #187.

Legacy Capital Wealth Partners first reported a position in CVS in Q1 2023 and has held it in 9 quarters since. The position peaked at $709K in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Legacy Capital Wealth Partners held 5,215 shares of CVS Health worth $539K as of Q2 2026.
  • Legacy Capital Wealth Partners bought 70 CVS Health shares in Q2 2026, an estimated $6.25K.
  • CVS Health made up 0.1% of Legacy Capital Wealth Partners's portfolio in Q2 2026, its #187 holding.
  • Legacy Capital Wealth Partners first reported a position in CVS Health in Q1 2023 and has held it in 9 quarters since.
  • Legacy Capital Wealth Partners's CVS Health position peaked at $709K in Q4 2023.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Legacy Capital Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.